Organogenesis Holdings Inc. (Nasdaq: ORGO) is a leading regenerative medicine company that focuses on developing, manufacturing, and commercializing product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets. On February 13th and 14th, the company announced that management will participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference, to be held at the Cliff Lodge in Snowbird, UT. The participation will include 1×1 meetings on February 14th, with no formal presentation.
Organogenesis Holdings Inc. offers a comprehensive portfolio of innovative regenerative products aimed at addressing patient needs across the continuum of care. The company’s main focus is in the advanced wound care and surgical and sports medicine markets. For more information about Organogenesis Holdings Inc., visit www.organogenesis.com.
For investor inquiries, please contact ICR Westwicke through Mike Piccinino, CFA at OrganoIR@westwicke.com. Press and media inquiries can be directed to Organogenesis at firstname.lastname@example.org.